Applications of Surface Plasmon Resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes

Sensors (Switzerland)

Volumn 12, Issue 12, 2012, Pages 16420-16432

  Canovi, Mara ^a   Lucchetti, Jacopo ^a   Stravalaci, Matteo ^a   Re, Francesca ^b   Moscatelli, Davide ^c   Bigini, Paolo ^a   Salmona, Mario ^a   Gobbi, Marco ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c POLITECNICO DI MILANO   (Italy)

Author keywords

Nanoparticles; Protein corona; Surface plasmon resonance

Indexed keywords

BIOLOGICAL FLUIDS; BIOLOGICAL TARGETS; BIOMOLECULAR INTERACTIONS; CHARACTERIZATION OF NANOPARTICLES; NANOPARTICLE (NPS); NOVEL APPLICATIONS; PHARMACOKINETIC PROFILES; PROTEIN CORONAS;

NANOPARTICLES; PLASMONS; PROTEINS;

SURFACE PLASMON RESONANCE;

LIGAND; NANOPARTICLE;

ARTICLE; CHEMISTRY; GENETIC PROCEDURES; HUMAN; SURFACE PLASMON RESONANCE;

BIOSENSING TECHNIQUES; HUMANS; LIGANDS; NANOPARTICLES; SURFACE PLASMON RESONANCE;

EID: 84871700095     PISSN: 14248220     EISSN: None     Source Type: Journal    
DOI: 10.3390/s121216420     Document Type: Article

References (51)

1. Kim, B.Y.; Rutka, J.T.; Chan, W.C. Nanomedicine. N. Engl. J. Med. 2010, 363, 2434-2443.
2. Riehemann, K.; Schneider, S.W.; Luger, T.A.; Godin, B.; Ferrari, M.; Fuchs, H. Nanomedicine-challenge and perspectives. Angew. Chem. Int. Ed. Engl. 2009, 48, 872-897.
3. Petros, R.A.; DeSimone, J.M., Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 2010, 9, 615-627.
4. Moghimi, S.M.; Szebeni, J. Stealth liposomes and long circulating nanoparticles: Critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 2003, 42, 463-478.
5. Lundqvist, M.; Stigler, J.; Elia, G.; Lynch, I.; Cedervall, T.; Dawson, K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. USA 2008, 105, 14265-14270.
6. Monopoli, M.P.; Bombelli, F.B.; Dawson, K.A. Nanobiotechnology: Nanoparticle coronas take shape. Nat. Nanotechnol. 2011, 6, 11-12.
7. Monopoli, M.P.; Walczyk, D.; Campbell, A.; Elia, G.; Lynch, I.; Bombelli, F.B.; Dawson, K.A. Physical-chemical aspects of protein corona: Relevance to in vitro and in vivo biological impacts of nanoparticles. J. Am. Chem. Soc. 2011, 133, 2525-2534.
8. Tenzer, S.; Docter, D.; Rosfa, S.; Wlodarski, A.; Kuharev, J.; Rekik, A.; Knauer, S.K.; Bantz, C.; Nawroth, T.; Bier, C.; et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: A comprehensive quantitative proteomic analysis. ACS Nano 2011, 5, 7155-7167.
9. Hong, S.; Leroueil, P.R.; Majoros, I.J.; Orr, B.G.; Baker, J.R., Jr.; Banaszak Holl, M.M. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem. Biol. 2007, 14, 107-115.
10. Stella, B.; Arpicco, S.; Peracchia, M.T.; Desmaele, D.; Hoebeke, J.; Renoir, M.; D'Angelo, J.; Cattel, L.; Couvreur, P. Design of folic acid-conjugated nanoparticles for drug targeting. J. Pharm. Sci. 2000, 89, 1452-1464.
11. Reddy, L.H.; Couvreur, P. Nanotechnology for therapy and imaging of liver diseases. J. Hepatol. 2011, 55, 1461-1466.
12. Colombo, G.; Margosio, B.; Ragona, L.; Neves, M.; Bonifacio, S.; Annis, D.S.; Stravalaci, M.; Tomaselli, S.; Giavazzi, R.; Rusnati, M.; et al. Non-peptidic thrombospondin-1 mimics as fibroblast growth factor-2 inhibitors: An integrated strategy for the development of new antiangiogenic compounds. J. Biol. Chem. 2010, 285, 8733-8742.
13. Rich, R.L.; Myszka, D.G. Higher-throughput, label-free, real-time molecular interaction analysis. Anal. Biochem. 2007, 361, 1-6.
14. Gobbi, M.; Colombo, L.; Morbin, M.; Mazzoleni, G.; Accardo, E.; Vanoni, M.; Del Favero, E.; Cantu, L.; Kirschner, D.A.; Manzoni, C.; et al. Gerstmann-straussler-scheinker disease amyloid protein polymerizes according to the "Dock-and-lock" Model. J. Biol. Chem. 2006, 281, 843-849.
15. Gesuete, R.; Storini, C.; Fantin, A.; Stravalaci, M.; Zanier, E.R.; Orsini, F.; Vietsch, H.; Mannesse, M.L.; Ziere, B.; Gobbi, M.; et al. Recombinant c1 inhibitor in brain ischemic injury. Ann. Neurol. 2009, 66, 332-342.
16. Myszka, D.G. Kinetic analysis of macromolecular interactions using surface plasmon resonance biosensors. Curr. Opin. Biotechnol. 1997, 8, 50-57.
17. Bravman, T.; Bronner, V.; Lavie, K.; Notcovich, A.; Papalia, G.A.; Myszka, D.G. Exploring "One-shot" Kinetics and small molecule analysis using the proteon xpr36 array biosensor. Anal. Biochem. 2006, 358, 281-288.
18. Gobbi, M.; Re, F.; Canovi, M.; Beeg, M.; Gregori, M.; Sesana, S.; Sonnino, S.; Brogioli, D.; Musicanti, C.; Gasco, P.; et al. Lipid-based nanoparticles with high binding affinity for amyloidbeta1-42 peptide. Biomaterials 2010, 31, 6519-6529.
19. Stravalaci, M.; Beeg, M.; Salmona, M.; Gobbi, M. Use of surface plasmon resonance to study the elongation kinetics and the binding properties of the highly amyloidogenic abeta(1-42) peptide, synthesized by depsi-peptide technique. Biosens Bioelectron 2010, 26, 2772-2775.
20. Dossi, M.; Ferrari, R.; Dragoni, L.; Martignoni, C.; Gaetani, P.; D'Incalci, M.; Morbidelli, M.; Moscatelli, D. Synthesis of fluorescent pmma-based nanoparticles. Macromol. Mater. Eng. 2012, doi:10.1002/mame.201200122.
21. Tassa, C.; Duffner, J.L.; Lewis, T.A.; Weissleder, R.; Schreiber, S.L.; Koehler, A.N.; Shaw, S.Y. Binding affinity and kinetic analysis of targeted small molecule-modified nanoparticles. Bioconjug. Chem. 2010, 21, 14-19.
22. Cooper, M.A.; Hansson, A.; Lofas, S.; Williams, D.H. A vesicle capture sensor chip for kinetic analysis of interactions with membrane-bound receptors. Anal. Biochem. 2000, 277, 196-205.
23. Besenicar, M.; Macek, P.; Lakey, J.H.; Anderluh, G. Surface plasmon resonance in protein-membrane interactions. Chem. Phys. Lipids 2006, 141, 169-178.
24. Erb, E.M.; Chen, X.; Allen, S.; Roberts, C.J.; Tendler, S.J.; Davies, M.C.; Forsen, S. Characterization of the surfaces generated by liposome binding to the modified dextran matrix of a surface plasmon resonance sensor chip. Anal. Biochem. 2000, 280, 29-35.
25. Anderluh, G.; Besenicar, M.; Kladnik, A.; Lakey, J.H.; Macek, P. Properties of nonfused liposomes immobilized on an l1 biacore chip and their permeabilization by a eukaryotic pore-forming toxin. Anal. Biochem. 2005, 344, 43-52.
26. Baird, C.L.; Courtenay, E.S.; Myszka, D.G. Surface plasmon resonance characterization of drug/liposome interactions. Anal. Biochem. 2002, 310, 93-99.
27. Schlattner, U.; Wallimann, T. A quantitative approach to membrane binding of human ubiquitous mitochondrial creatine kinase using surface plasmon resonance. J. Bioenerg. Biomembr. 2000, 32, 123-131.
28. MacKenzie, C.R.; Hirama, T.; Lee, K.K.; Altman, E.; Young, N.M. Quantitative analysis of bacterial toxin affinity and specificity for glycolipid receptors by surface plasmon resonance. J. Biol. Chem. 1997, 272, 5533-5538.
29. Graneli, A.; Edvardsson, M.; Hook, F. DNA-based formation of a supported, three-dimensional lipid vesicle matrix probed by qcm-d and spr. Chemphyschem 2004, 5, 729-733.
30. Cedervall, T.; Lynch, I.; Lindman, S.; Berggard, T.; Thulin, E.; Nilsson, H.; Dawson, K.A.; Linse, S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc. Natl. Acad. Sci. USA 2007, 104, 2050-2055.
31. Cabaleiro-Lago, C.; Quinlan-Pluck, F.; Lynch, I.; Lindman, S.; Minogue, A.M.; Thulin, E.; Walsh, D.M.; Dawson, K.A.; Linse, S. Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J. Am. Chem. Soc. 2008, 130, 15437-15443.
32. Mourtas, S.; Canovi, M.; Zona, C.; Aurilia, D.; Niarakis, A.; La Ferla, B.; Salmona, M.; Nicotra, F.; Gobbi, M.; Antimisiaris, S.G. Curcumin-decorated nanoliposomes with very high affinity for amyloid-beta1-42 peptide. Biomaterials 2011, 32, 1635-1645.
33. Canovi, M.; Markoutsa, E.; Lazar, A.N.; Pampalakis, G.; Clemente, C.; Re, F.; Sesana, S.; Masserini, M.; Salmona, M.; Duyckaerts, C.; et al. The binding affinity of anti-abeta1-42 mab-decorated nanoliposomes to abeta1-42 peptides in vitro and to amyloid deposits in post-mortem tissue. Biomaterials 2011, 32, 5489-5497.
34. Orsini, F.; Villa, P.; Parrella, S.; Zangari, R.; Zanier, E.R.; Gesuete, R.; Stravalaci, M.; Fumagalli, S.; Ottria, R.; Reina, J.J.; et al. Targeting mannose binding lectin confers long lasting protection with a surprisingly wide therapeutic window in cerebral ischemia. Circulation 2012, 126, 1484-1494.
35. Dobrovolskaia, M.A.; Patri, A.K.; Zheng, J.; Clogston, J.D.; Ayub, N.; Aggarwal, P.; Neun, B.W.; Hall, J.B.; McNeil, S.E. Interaction of colloidal gold nanoparticles with human blood: Effects on particle size and analysis of plasma protein binding profiles. Nanomedicine 2009, 5, 106-117.
36. Walkey, C.D.; Olsen, J.B.; Guo, H.; Emili, A.; Chan, W.C. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J. Am. Chem. Soc. 2012, 134, 2139-2147.
37. Nel, A.E.; Madler, L.; Velegol, D.; Xia, T.; Hoek, E.M.; Somasundaran, P.; Klaessig, F.; Castranova, V.; Thompson, M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8, 543-557.
38. Lundqvist, M.; Stigler, J.; Cedervall, T.; Berggard, T.; Flanagan, M.B.; Lynch, I.; Elia, G.; Dawson, K. The evolution of the protein corona around nanoparticles: A test study. ACS Nano 2011, 5, 7503-7509.
39. Casals, E.; Pfaller, T.; Duschl, A.; Oostingh, G.J.; Puntes, V. Time evolution of the nanoparticle protein corona. ACS Nano. 2010, 4, 3623-3632.
40. Dell'Orco, D.; Lundqvist, M.; Oslakovic, C.; Cedervall, T.; Linse, S. Modeling the time evolution of the nanoparticle-protein corona in a body fluid. PLoS One 2010, 5, e10949.
41. Cedervall, T.; Lynch, I.; Foy, M.; Berggard, T.; Donnelly, S.C.; Cagney, G.; Linse, S.; Dawson, K.A. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew. Chem. Int. Ed. Engl. 2007, 46, 5754-5756.
42. Hillaireau, H.; Couvreur, P. Nanocarriers' entry into the cell: Relevance to drug delivery. Cell. Mol. Life Sci. 2009, 66, 2873-2896.
43. Owens, D.E., 3rd; Peppas, N.A. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 2006, 307, 93-102.
44. Moghimi, S.M.; Hunter, A.C.; Murray, J.C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 2001, 53, 283-318.
45. Ogawara, K.; Furumoto, K.; Nagayama, S.; Minato, K.; Higaki, K.; Kai, T.; Kimura, T. Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: Implications for rational design of nanoparticles. J. Control. Release 2004, 100, 451-455.
46. Kreuter, J.; Shamenkov, D.; Petrov, V.; Ramge, P.; Cychutek, K.; Koch-Brandt, C.; Alyautdin, R. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J. Drug Target. 2002, 10, 317-325.
47. Michaelis, K.; Hoffmann, M.M.; Dreis, S.; Herbert, E.; Alyautdin, R.N.; Michaelis, M.; Kreuter, J.; Langer, K. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain. J. Pharmacol. Exp. Ther. 2006, 317, 1246-1253.
48. Zensi, A.; Begley, D.; Pontikis, C.; Legros, C.; Mihoreanu, L.; Wagner, S.; Buchel, C.; von Briesen, H.; Kreuter, J. Albumin nanoparticles targeted with apo e enter the cns by transcytosis and are delivered to neurones. J. Control. Release 2009, 137, 78-86.
49. Wagner, S.; Zensi, A.; Wien, S.L.; Tschickardt, S.E.; Maier, W.; Vogel, T.; Worek, F.; Pietrzik, C.U.; Kreuter, J.; von Briesen, H. Uptake mechanism of apoe-modified nanoparticles on brain capillary endothelial cells as a blood-brain barrier model. PLoS One 2012, 7, e32568.
50. Re, F.; Cambianica, I.; Sesana, S.; Salvati, E.; Cagnotto, A.; Salmona, M.; Couraud, P.O.; Moghimi, S.M.; Masserini, M.; Sancini, G. Functionalization with apoe-derived peptides enhances the interaction with brain capillary endothelial cells of nanoliposomes binding amyloid-beta peptide. J. Biotechnol. 2010, 156, 341-346.
51. Re, F.; Cambianica, I.; Zona, C.; Sesana, S.; Gregori, M.; Rigolio, R.; La Ferla, B.; Nicotra, F.; Forloni, G.; Cagnotto, A.; et al. Functionalization of liposomes with apoe-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model. Nanomedicine 2011, 7, 551-559.